My illustration entitled: “The Family Consent Table” — Parents and a clinician review a genetic intervention plan while the child’s seat and voice are visibly central, not absent.
A child cannot sign a contract for their future. Yet the decisions now emerging around genetic intervention, neural devices, cognitive enhancement and biological data may shape a child’s body, mind, identity and opportunities long before that child can understand or challenge them.
Parents and clinicians must make decisions for children. This responsibility is unavoidable and often compassionate. A child may need urgent treatment, assistive technology, rehabilitation or protection from a serious inherited condition. To refuse all intervention in the name of future autonomy would be careless. But to treat parental permission as unlimited authority would be equally careless.
The sovereign child is the principle that every minor is a person in formation, not a product in development. Their voice, welfare, privacy and future capacity to choose must remain central whenever adults consider interventions that reach into the body, brain or genome.
Human-Sovereignty Transhumanism supports responsible technology that heals, restores and expands human potential. It rejects the transformation of children into projects for parental ambition, commercial experimentation or institutional control. Adults may have reasons to decide for a child. They do not have an automatic right to prewrite the child’s identity.
Care is not ownership
Parents are entrusted with a child’s care, but care does not make a child property. A parent’s role is to protect a young person’s developing life and help them acquire the capacity to direct it. The same should be true of medicine, schools and technology providers.
This distinction becomes essential when technology makes deeper intervention possible. A medication may affect mood. A neural device may assist movement or communication. A genetic procedure may alter health prospects. Each can be justified in particular circumstances. Each may also reach into parts of life that define a child’s future sense of self.
The question should not be, “What can adults decide?” It should be, “What decision best protects this child’s welfare while preserving their future authority over their own body and mind?” That change in emphasis is the beginning of responsible governance.
A child’s future should be shaped with their voice and consent at the centre—not decided over their head.
Consent, assent and the developing person
Young children cannot provide the same informed consent expected from adults. But this does not mean their preferences are irrelevant. As children develop understanding, they can express comfort, fear, disagreement and values. Their assent should be sought wherever their age and circumstances make that possible.
Assent is not a symbolic courtesy. It is a practice of respecting emerging agency. A child who is given understandable explanations, time to ask questions and a genuine opportunity to express concern begins to learn that their body and mind belong to them. A child who is treated only as the subject of adult decisions learns the opposite lesson.
Adults should explain interventions in language appropriate to the child’s maturity. They should distinguish what is necessary for immediate health from what is optional or experimental. They should revisit decisions as the child grows. A choice made for an infant should not become a permanent technological arrangement simply because no one returns to ask the older child what they think.
Where an intervention is elective, irreversible or directed at enhancement rather than urgent treatment, the burden of justification should be much higher. Whenever delay is safe, it may be more respectful to wait until the young person can participate meaningfully in the choice.
Neurotechnology reaches beyond the surface
Neurotechnology offers remarkable possibilities. It may help a child control a prosthetic, communicate after injury, manage a neurological condition or participate more fully in the world. These uses deserve careful support. But the brain is not merely another organ. It is closely connected to memory, attention, personality, emotion and the private experience through which a person knows themselves.
For that reason, technologies that read from, stimulate or influence neural activity require special restraint. The child’s need for assistance must never become an excuse for unnecessary monitoring, behavioural control or data extraction. A neural system designed to aid communication should not silently build a profile for schools, insurers or advertisers. A device used in therapy should not become a channel through which a provider claims continuing access to the child’s inner life.
Children require not only bodily privacy but mental privacy. Their developing thoughts, reactions and patterns of attention should not be treated as a resource to be captured because an interface can measure them. The mind remains sovereign territory, including when it is young, vulnerable or assisted by technology.
Therapy must not become a pathway to compulsion
Technology that begins as therapy can gradually become an expectation. A device offered to help concentration may later be regarded as the standard for academic performance. A wearable introduced for health monitoring may become a requirement for insurance or school participation. A neural aid may be presented as optional, but children and parents may feel they have no real choice if refusal risks exclusion.
This is the upgrade trap applied to childhood. When adults and institutions set a new technological baseline, they may pressure families to modify children in order to remain competitive. The language of opportunity can become a language of coercion.
Schools, employers and public institutions must never create rules that effectively require children to be enhanced in order to access ordinary education, social participation or future work. The freedom to enhance must be matched by an equal freedom to remain unenhanced. A child should not be made to feel inadequate because their family chooses caution, cannot afford a technology or believes that a different path is right for them.
Genetic intervention and the unwritten future
Genetic medicine may protect children from serious inherited disease. Such intervention can be an expression of care, especially when it prevents grave and avoidable suffering. But genetic power must be guided by humility. A child’s genome is not a design brief for adult preferences.
The more an intervention is irreversible, heritable or unrelated to serious medical need, the more carefully it should be examined. A decision that affects a future child cannot be treated as a routine consumer choice. It has consequences for identity, diversity and the range of lives the person may later choose to lead.
The genetic right to an open future requires us to distinguish between protecting a child from serious harm and narrowing the child toward an ideal selected by others. The first can expand freedom. The second risks converting a person into a product of social competition.
No child should be valued as an achievement of genetic planning. Their dignity does not depend on how closely they match a parent’s hopes, a market’s preferences or an institution’s definition of normality.
The right to pause, defer and revisit
In a culture excited by technological possibility, delay can look like failure. But the right to pause is a vital protection for minors. When a decision is not medically urgent and cannot easily be reversed, waiting may be the most responsible option.
A pause allows the child to mature, the evidence to improve and the family to understand long-term consequences. It protects against decisions made under marketing pressure, fear of falling behind or misplaced certainty about a child’s future identity. To defer an elective intervention is not necessarily to deny a child opportunity. It may be to preserve their opportunity to choose for themselves.
Policies should therefore build in regular review. A child using an assistive or neural technology should have age-appropriate opportunities to reconsider settings, data use and ongoing participation. A young person approaching maturity should receive a clear handover of authority over their own medical, genetic and technological records.
My illustration “The Family Consent Table” work-in-progress. The art affirms that a child’s future should be shaped with their voice and consent at the centre—not decided over their head.
Children must not inherit surveillance
Children now grow up surrounded by systems that collect information about learning, health, movement and behaviour. Neurotechnology and genetic services can add even more intimate forms of data. This creates the risk that a child arrives at adulthood with a long record of biological and cognitive information controlled by institutions they never chose.
That is not a neutral inheritance. Records can shape how schools, insurers, employers and even families view a person. A prediction may be mistaken for destiny. A developmental difference may be treated as a permanent limitation. A child’s early reactions may be preserved long after they cease to represent the person they become.
Data about minors must therefore be subject to strict purpose limits. It should be collected only when genuinely necessary, secured carefully and separated from unrelated commercial or administrative uses. Children should gain access to their own information as they mature, along with the ability to correct errors, restrict sharing and seek deletion where possible.
No one should enter adult life already trapped by a profile created in childhood.
Equality for enhanced and unenhanced children
Technology may deepen existing inequality if some children receive access to expensive forms of therapeutic or cognitive support while others do not. This injustice should concern us. Yet equality does not mean forcing every child into the same technological pathway.
Enhanced and unenhanced children must remain equal in dignity, legal protection and educational opportunity. A child who uses a device should not be treated as less human or less private because of it. A child who does not use one should not be treated as less capable or less deserving because they remain unenhanced.
The goal of policy should be to widen opportunity, not to prewrite identity. Public investment should support healthcare, accessible education, disability inclusion and fair access to genuinely beneficial therapies. It should not create a hierarchy in which technological modification becomes the measure of a child’s worth.
Who is accountable when adults decide?
When adults make decisions for children, responsibility must remain visible. Parents, clinicians, researchers, schools, manufacturers and regulators cannot all point elsewhere if harm occurs. The more experimental or intrusive an intervention, the clearer the lines of accountability must be.
Families need access to independent advice, understandable information and avenues for challenge. Children and young people need advocates who can represent their interests when those interests differ from the preferences of parents, institutions or providers. Complaints and review should not depend on wealth, technical knowledge or the willingness of a company to listen.
Accountability is not hostility to innovation. It is how society earns the trust needed for responsible innovation. A child’s vulnerability increases the duty of everyone involved to act transparently and accept responsibility for the consequences of their decisions.
A sovereign-child standard
Any proposal to use neurotechnology or genetic intervention with a minor should meet a clear standard:
- Child welfare first: the intervention serves the child’s genuine health, agency or well-being—not adult ambition or institutional convenience.
- Age-appropriate assent: the child’s understanding, preferences and objections are taken seriously as their capacity develops.
- Higher safeguards for irreversible choices: elective, heritable or identity-shaping interventions require stronger evidence and independent review.
- Mental and genetic privacy: neural and genomic data are protected from unnecessary collection, profiling and repurposing.
- Right to pause and revisit: delay is available where safe, and continuing participation is reviewed as the child matures.
- Freedom from coercion: families are not punished or excluded for declining non-essential enhancement.
- Continuity and exit: children are not trapped in provider-controlled systems and can gain control over their own technology and data.
- Independent accountability: clear remedies exist when the child’s rights, privacy or welfare are harmed.
Protect the future person
The child is not merely a future adult. They are already a person, entitled to care, respect and protection. But they are also a future sovereign individual whose ability to decide must be preserved. This is the moral responsibility that makes decisions about neurotechnology and genetic intervention so serious.
We should use knowledge compassionately to reduce suffering and broaden opportunity. We should never use it to manufacture perfect people, secure permanent access to young minds or make children conform to a technological ideal chosen by others.
Human-Sovereignty Transhumanism calls us to protect the child’s present welfare without closing the child’s future freedom. Parents may guide. Clinicians may heal. Technology may assist. But the child’s body, mind, genome and future must never become the property of those who arrive first.